INTRODUCTION 52
Aromatic diamidines are DNA minor groove-binding ligands (MGBLs), which 53 present striking broad-spectrum antimicrobial effects (28). Although this class of 54 compounds displays significant in vitro and in vivo activity against fungi, amoeba, 55 bacteria and especially protozoan parasites, certain structures can show toxicity 56 towards mammalian cells (23). In addition, aromatic diamidines in general lack oral 57 bioavailability, which limits their use (28). To overcome these limitations, prodrugs 58 such as the methamidoxime prodrug of furamidine (DB289), which is currently 59 undergoing phase III clinical trials against human African trypanosomiasis, have 60 been developed (29) . Trypanosoma cruzi is the etiological agent of Chagas' 61 disease, a zoonosis considered a major public health problem in the developing 62 countries of Central and South America (14). The disease is widespread in 63 endemic areas of Latin America and it has been estimated that the overall 64 prevalence of human infection is about 17 million cases and that approximately 65 120 million people are at risk of contracting the infection (30). However, up to now 66 there is neither an effective vaccine nor a satisfactory treatment for the disease. 67
Drug therapy depends mostly upon nitrofurans and nitroimidazoles such as 68 nifurtimox and benznidazole (4, 26, 27) . and untreated parasite population that displayed depolarization of the 133 mitochondrial membrane (marked as M2). All assays were run 3 times at least in 134 duplicates and Student's t-test was applied to ascertain the statistical significance 135 of the observed differences (p<0.05). 136
Ultrastructural analysis. 10 8 bloodstream trypomastigotes were treated or not 137
for 24 h at 37°C with the corresponding IC50 concentration of each drug. After 138 incubation, the parasites were fixed for 60 min at 4 °C with 2.5% glutaraldehyde 139 and 2.5 mM CaCl 2 in 0.1 M cacodylate buffer, pH 7.2 and post-fixed for 1 h at 4 °C 140 with 1% OsO 4 , 0.8% potassium ferricyanide and 2.5 mM CaCl 2 using this same 141 buffer. Then, the samples were routinely processed for transmission electron 142 microscopy (TEM) and examined in a Zeiss EM10C electron microscope 143 (Oberkochen, Germany). 144
145

RESULTS
146
In addition to the trypanocidal effect of aromatic diamidines upon T. cruzi in 147 vitro as well as in vivo (8,9), our recent report showed an excellent activity of 148 reversed amidines during the treatment of bloodstream forms at 4°C in the 149
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on July 5, 2017 by guest http://aac.asm.org/ Downloaded from presence of blood constituents (22). Then, our first approach in the present study 150 was to evaluate the activity of three different reversed amidines (DB889, DB702 151 and DB786), and one structurally related diguanidine (DB711) against bloodstream 152 trypomastigotes of T. cruzi, during their treatment at 37ºC. Our results showed that 153 DB889 displayed a dose and time-dependent trypanocidal effect: as early as after 154 2 hours of incubation with 1.18 µM we found about 55% of parasite lysis, reaching 155 a 100% of death after 24 hours of treatment with 3.5 µM (Fig. 2A) . Similar data 156
were noted when the trypomastigotes were incubated for 2 hours with the other 157 two reversed amidines: 55 and 50% parasite death for DB702 and DB786, 158 respectively. However, when the parasites were incubated for 24 hours with 3.5µM, 159 both drugs reduced the number of viable parasites by about 95% (Fig. 2B and 2C) . 160
In fact, DB786 was extremely effective even under nanomolar doses: the treatment 161 of bloodstream forms for 24 hours with 0.014µM DB786 lead to about 49% of 162 parasite death (Fig.2C Inset) . DB711 was the less effective, presenting 23 and 163 84% of death with 32 µM after 2 and 24 hours of parasite drug exposure, 164 respectively (Fig. 2D) . 165
Based on the IC 50 /24h values established for each drug (Table) , the 166 bloodstream trypomastigotes were treated and processed for transmission electron 167 microscopy to investigate morphological damage induced by the compounds 168 studied at the ultrastructural level. Untreated parasites presenting typical 169 organelles such as the endoplasmatic reticulum, nucleus, mitochondria and 170 flagellum (arrow) can be easily identified (Fig. 3A) . Note the single giant 171 mitochondrion that branches throughout the parasite and contains a large contrasting to the untreated group, where only about 17±13% of the parasites 198 already displayed decreased MMP (Fig. 3I-L) . On the other hand, the treatment of 199 the parasites with the diguanidine DB711 did not result in statistically significant 200 (p<0.31) reduction of MMP (Fig. 3M) . Fig. 4A and 4B ). As already noted during the 210 treatment of the bloodstream trypomastigotes (Fig. 3) , alterations related to the 211 amastigotes nuclei and mitochondria were always the most common and frequent 212 effects induced by the reversed amidine (Fig. 4) . Besides these alterations in the 213 mitochondria (swelling, disorganization of the kinetoplast and presence of low 214 eletrodense structures) ( Fig. 4D and 4E ), and in the nuclear morphology (Fig. 4C) , 215 other effects also included the vacuolization and loss of the cytoplasm components 216 (Fig. 4C, asteriks) , disorganization of the subpellicular microtubules, which are 217 absent in distended membrane areas (Fig. 4H) , and an intense vesicular profiles in 218 the flagellar pocket ( Fig. 4F and 4G) . Chagasic patients and diamidines are considered potential drugs since they 229 present broad-spectrum activity against several parasitic agents both in vivo and in 230 vitro (23). In the present study we explored the effects on the parasite targets for 231 three "reversed" amidines and one diguanidine, which display related structures. 232
Our data suggest that small variation in chemical structure can result in significant 233 differences in the antiparasitic potency: even after short periods of incubation (2 234
In our present transmission electron microscopy (TEM) analysis, all reversed 241 amidines, and to a lesser extent the diguanidine, induced marked and frequent 242 alteration in the nuclei and mitochondria of both amastigotes and trypomastigotes. Due to well-known side effects, low bioavailability and the requirement of 296 parenteral administration of the aromatic diamidines, the search for novel aromatic 297 dications has been intensively investigated (28). However, these previous studies 298 have largely focused on African trypanosome infections and few studies have been 299 designed to investigate the potential effect of aromatic diamidines against T. cruzi 300 (23, 28). As already reported (25, 22), we presently found a high activity of the 301 "reversed" amidines against T. cruzi upon the parasite forms present in the 302 vertebrate hosts (intracellular amastigotes and bloodstream trypomastigotes), at 303 very low micromolar doses that do not affect the viability of mammalian cells. The 304 mechanism by which these dicationic molecules reach the intracellular milieu 305 remains largely unknown and it is possible that the nuclear membrane of the 306 parasite (presently found with striking alterations), as well as the mitochondrial 307 membrane, may be more permeable to dications than the nuclear membrane of 308 
